Epidemiology and Clinical Characteristics of Patients with Multiple Myeloma. Results of a Prospective Multicenter Study in Russian Federation

被引：2
|
作者：
Solovev, Maxim V. [1 ]
Mendeleeva, Larisa P. [1 ]
Pokrovskaya, Olga S. [1 ]
Gemdzhian, Eduard [2 ]
Volodicheva, Elena [3 ]
Anchukova, Lyudmila V. [4 ]
Menshakova, Svetlana N. [5 ]
Osyunikhina, Svetlana M. [6 ]
Voytsekhovski, Vladimir V. [7 ]
Savchenko, Valeri G. [8 ]
机构：
[1] Natl Res Ctr Hematol, Dept High Dose Chemotherapy, Moscow, Russia
[2] Natl Res Ctr Hematol, Biostat, Moscow, Russia
[3] Tula Reg Clin Hosp, Tula, Russia
[4] Reg Clin Hosp, Vologda, Russia
[5] Reg Clin Hosp, Tver, Russia
[6] Reg Clin Hosp, Saransk, Russia
[7] Reg Clin Hosp, Blagoveshchensk, Russia
[8] Natl Res Ctr Hematol, Moscow, Russia
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.4248.4248
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study
    Cherry, Benjamin M.
    Korde, Neha
    Kwok, Mary
    Manasanch, Elisabet E.
    Bhutani, Manisha
    Mulquin, Marcia
    Zuchlinski, Diamond
    Yancey, Mary Ann
    Maric, Irina
    Calvo, Katherine R.
    Braylan, Raul
    Stetler-Stevenson, Maryalice
    Yuan, Constance
    Tembhare, Prashant
    Zingone, Adriana
    Costello, Rene
    Roschewski, Mark J.
    Landgren, Ola
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2215 - 2218
  • [32] A study of autologous stem cell transplantation in young patients with multiple myeloma.
    Wechalekar, AD
    Reece, D
    Sutton, D
    Franke, N
    Chen, C
    Stewart, AK
    BLOOD, 2002, 100 (11) : 433A - 433A
  • [33] Phase II study of SU5416 in patients with multiple myeloma.
    Zangari, M
    Stopeck, AT
    Karp, J
    Lancet, J
    Silverman, L
    Smolich, B
    Cherrington, J
    Jacobs, M
    Albitar, M
    Giles, FJ
    BLOOD, 2001, 98 (11) : 164A - 164A
  • [34] The Risk Factors of NAFLD in Population of Russian Federation. Results of Open Multicenter Prospective Study Direg_1_01903
    Tsukanov, Vladislav V.
    Tonkikh, Julia L.
    Kupershtein, Elena J.
    Amelchugova, Olga S.
    Kasparov, Edward V.
    Vasyutin, Alexander V.
    Lukicheva, Elina V.
    GASTROENTEROLOGY, 2011, 140 (05) : S701 - S702
  • [35] Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study
    Kumar, Lalit
    Melinkeri, Sameer
    Ganesan, Prasanth
    Kumar, Jeevan
    Biswas, Ghanashyam
    Kilara, Nalini
    Pathalingappa, Harish
    Prasad, S. V. S. S.
    Jain, Minish
    Mishra, Sourav Kumar
    Prasad, Saurabh
    Boyella, Pavan Kumar
    Sahoo, Ranjit Kumar
    Bondarde, Shailesh
    Shah, Sandip
    Rege, Milind
    Deb, Uttiya
    Korde, Tanuja
    Dixit, Jitendra
    FUTURE ONCOLOGY, 2024, 20 (04) : 191 - 205
  • [36] Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT)
    Ptushkin, Vadim V.
    Kunst, Michail A.
    Mitina, Tatiana A.
    Konstantinova, Tatiana S.
    Rachkova, Natalia N.
    Shelekhova, Tatiana, V
    Elykomov, Ilya, V
    Kuchma, Galina B.
    Farizova, Kiriena O.
    Vinogradova, Olga Yu
    Nikitin, Eugene A.
    Pashanov, Evgeny D.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (07) : 827 - 835
  • [37] Epidemiology and risk factors for the development of infectious complications in newly diagnosed multiple myeloma: a multicenter prospective cohort study in Uruguay
    Riva, Eloisa
    Garrido, David
    Villano, Fiorella
    Bove, Virginia
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (04) : 434 - 442
  • [38] A randomized multicenter study of bendamustine/prednisone versus melphalane/prednisone in the primary treatment of multiple myeloma.
    Pönisch, W
    Mitrou, PS
    Merkle, KM
    Rieth, A
    Herold, M
    Schulze, A
    Bittrich, A
    Assmann, M
    Schirmer, V
    Wilhelm, G
    Dachselt, K
    Richter, P
    Subert, R
    Friedrich, T
    Helbig, W
    Niederwieser, D
    BLOOD, 1999, 94 (10) : 123A - 123A
  • [39] Clinical study of fludarabine, mitoxantrone, and dexamethasone in the treatment of refractory or relapsed multiple myeloma.
    Luo, SK
    Li, J
    Hong, WD
    Zhao, Y
    Tong, XZ
    BLOOD, 2005, 106 (11) : 380B - 380B
  • [40] Epidemiology of sepsis in Germany: results from a national prospective multicenter study
    Christoph Engel
    Frank M. Brunkhorst
    Hans-Georg Bone
    Reinhard Brunkhorst
    Herwig Gerlach
    Stefan Grond
    Matthias Gruendling
    Guenter Huhle
    Ulrich Jaschinski
    Stefan John
    Konstantin Mayer
    Michael Oppert
    Derk Olthoff
    Michael Quintel
    Max Ragaller
    Rolf Rossaint
    Frank Stuber
    Norbert Weiler
    Tobias Welte
    Holger Bogatsch
    Christiane Hartog
    Markus Loeffler
    Konrad Reinhart
    Intensive Care Medicine, 2007, 33 : 606 - 618
12345